跳至主要内容
临床试验/IRCT20211226053534N2
IRCT20211226053534N2尚未招募2 期

Evaluation of Vitamin B6 (pyridoxine) Effect on symptoms and quality of life in patients with irritable bowel syndrome (IBS)

Islamic Azad University0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Newly diagnosed patients with Irritable Bowel Syndrome (IBS) according to the Rome IV criteria
  • Age from 18 to 65 years old

排除标准

  • Personal History of malignant diseases of the gastrointestinal tract, Celiac disease, Lactose intolerance, Diverticulitis, Gastrointestinal infection, Hypothyroidism and hyperthyroidism
  • Presence of other diseases during colonoscopy in individuals over 50 years of age
  • Pregnancy and lactation
  • Allergy to the study drug
  • Lack of consent to participate in the study

研究者

相似试验

Evaluation of Vitamin B6 (pyridoxine) Effect on... | 临床试验